Accendra Health, Inc.ACHNYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-18.9%
5Y CAGR-17.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-18.9%/yr
vs +38.0%/yr prior
5Y CAGR
-17.4%/yr
Consistent
Acceleration
-56.9pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.08 | -16.8% |
| 2024 | 0.09 | -33.7% |
| 2023 | 0.14 | -3.3% |
| 2022 | 0.15 | -54.8% |
| 2021 | 0.32 | +60.0% |
| 2020 | 0.20 | +494.5% |
| 2019 | 0.03 | -15.7% |
| 2018 | 0.04 | -66.8% |
| 2017 | 0.12 | -45.2% |
| 2016 | 0.22 | - |